Royal London Asset Management Ltd. Sells 11,818 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

Royal London Asset Management Ltd. lessened its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 3.3% during the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 348,421 shares of the medical equipment provider’s stock after selling 11,818 shares during the period. Royal London Asset Management Ltd.’s holdings in Intuitive Surgical were worth $171,169,000 at the end of the most recent reporting period.

A number of other hedge funds have also recently added to or reduced their stakes in ISRG. Ridgewood Investments LLC bought a new position in shares of Intuitive Surgical in the 2nd quarter valued at $26,000. Godsey & Gibb Inc. increased its stake in shares of Intuitive Surgical by 140.0% in the 3rd quarter. Godsey & Gibb Inc. now owns 60 shares of the medical equipment provider’s stock valued at $29,000 after purchasing an additional 35 shares during the last quarter. LGT Financial Advisors LLC increased its stake in shares of Intuitive Surgical by 415.4% in the 2nd quarter. LGT Financial Advisors LLC now owns 67 shares of the medical equipment provider’s stock valued at $30,000 after purchasing an additional 54 shares during the last quarter. MidAtlantic Capital Management Inc. bought a new position in shares of Intuitive Surgical in the 3rd quarter valued at $33,000. Finally, Mark Sheptoff Financial Planning LLC bought a new position in shares of Intuitive Surgical in the 2nd quarter valued at $37,000. Institutional investors own 83.64% of the company’s stock.

Insider Activity

In other news, CEO Gary S. Guthart sold 18,151 shares of the business’s stock in a transaction dated Wednesday, October 30th. The stock was sold at an average price of $511.63, for a total value of $9,286,596.13. Following the transaction, the chief executive officer now directly owns 24,219 shares of the company’s stock, valued at $12,391,166.97. The trade was a 42.84 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, EVP Robert Desantis sold 238 shares of the business’s stock in a transaction dated Tuesday, September 10th. The shares were sold at an average price of $477.50, for a total value of $113,645.00. Following the completion of the transaction, the executive vice president now directly owns 5,506 shares in the company, valued at $2,629,115. This represents a 4.14 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 51,023 shares of company stock valued at $26,384,247 in the last ninety days. 0.90% of the stock is owned by company insiders.

Analysts Set New Price Targets

Several brokerages have recently issued reports on ISRG. Leerink Partners lifted their price target on Intuitive Surgical from $489.00 to $502.00 in a research note on Thursday, October 17th. Evercore ISI restated a “cautious” rating on shares of Intuitive Surgical in a research report on Friday, October 18th. Robert W. Baird boosted their price objective on Intuitive Surgical from $503.00 to $565.00 and gave the stock an “outperform” rating in a research report on Thursday, October 17th. Wells Fargo & Company boosted their price objective on Intuitive Surgical from $466.00 to $549.00 and gave the stock an “overweight” rating in a research report on Friday, October 18th. Finally, Morgan Stanley upgraded Intuitive Surgical from an “equal weight” rating to an “overweight” rating and boosted their price objective for the stock from $522.00 to $650.00 in a research report on Monday. One investment analyst has rated the stock with a sell rating, four have given a hold rating and fifteen have given a buy rating to the company’s stock. According to MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $536.61.

Intuitive Surgical Trading Up 1.5 %

Shares of ISRG opened at $549.95 on Thursday. The company has a market capitalization of $195.88 billion, a PE ratio of 88.42, a PEG ratio of 5.33 and a beta of 1.38. Intuitive Surgical, Inc. has a 12 month low of $304.50 and a 12 month high of $552.08. The stock’s 50-day moving average price is $513.56 and its two-hundred day moving average price is $472.07.

Intuitive Surgical (NASDAQ:ISRG) last announced its quarterly earnings data on Thursday, October 17th. The medical equipment provider reported $1.56 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.24 by $0.32. The company had revenue of $2.04 billion for the quarter, compared to the consensus estimate of $2.01 billion. Intuitive Surgical had a return on equity of 13.41% and a net margin of 28.51%. Equities research analysts predict that Intuitive Surgical, Inc. will post 5.45 EPS for the current fiscal year.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.